Triple Receptor Activation
Single molecule agonism at GLP-1, GIP, and glucagon receptors — the most comprehensive metabolic mechanism studied to date.
The most advanced compound in metabolic research. GLP-1 + GIP + Glucagon triple receptor agonist with 99%+ HPLC-verified purity.
Retatrutide (developmental code LY3437943) is a novel synthetic peptide that simultaneously activates three key metabolic receptors. In Phase 2 trials it produced the largest mean reductions in body weight ever recorded for a single agent.
Single molecule agonism at GLP-1, GIP, and glucagon receptors — the most comprehensive metabolic mechanism studied to date.
The unique glucagon agonism is what differentiates Retatrutide from Tirzepatide, accelerating energy expenditure in research models.
Eli Lilly Phase 2 published in NEJM (2023) demonstrated up to 24.2% mean body weight reduction at 48 weeks with the highest dose arm.
Manufactured under GMP-equivalent peptide synthesis protocols with full chain-of-custody documentation.
| Feature | Retatrutide | Tirzepatide | Semaglutide |
|---|---|---|---|
| Receptor targets | GLP-1 + GIP + Glucagon | GLP-1 + GIP | GLP-1 |
| Generation | Triple agonist (newest) | Dual agonist | Single agonist |
| Weight reduction (Phase 2/3) | ~24.2% | ~22.5% | ~14.9% |
| Energy expenditure boost | Yes (glucagon) | No | No |
| Pen kit dose | 40mg | 40mg | 8mg |
| Research demand 2025 | Highest | High | High |
Secure checkout, crypto and card payments accepted.
Shipped within 24h in temperature-controlled packaging.
Fully tracked. Reships free if customs intercepts.
Match the included Certificate of Analysis batch number.
Premium triple-agonist research peptide. Limited stock — current batch ships from EU warehouse.
Buy Retatrutide — £130Retatrutide (LY3437943) is a novel triple-agonist research peptide that simultaneously activates GLP-1, GIP, and glucagon receptors — currently the most advanced compound in metabolic research.
All orders ship discreetly via tracked express courier with cold-chain packaging. Free shipping on orders over £75. UK: 2 business days (Royal Mail). EU: 3 business days (EDP/Chronopost). 100% reshipment guarantee.
Every batch is third-party tested by HPLC and Mass Spectrometry, certified at ≥99% purity. A unique batch-numbered Certificate of Analysis (COA) is included in every shipment.
No. Retatrutide is currently in clinical trials and is not yet approved by any regulator. Synedica Labs sells this product strictly for in-vitro laboratory research only. Not for human or veterinary consumption.
Store the unmixed pen kit at 2–8°C (standard refrigerator). After reconstitution, use within 28 days kept refrigerated and protected from direct light.
We accept major credit/debit cards and cryptocurrency (BTC, ETH, USDT). All payments are processed securely.
We ship worldwide including USA, UK, EU, Canada, Australia, Brazil, Mexico, Japan, and most of Asia/Africa. Some restricted jurisdictions excluded — see Shipping page.